==== Front Front Microbiol Front Microbiol Front. Microbiol. Frontiers in Microbiology 1664-302X Frontiers Media S.A. 10.3389/fmicb.2023.1224271 Microbiology Correction Corrigendum: Molecular epidemiology and comparative genomics of carbapenemase-producing Escherichia coli isolates from 19 tertiary hospitals in China from 2019 to 2020 Ko Weihsin 1 † Tseng Songlu 2 † Chou Chiahsin 3 Li Tianmeng 4 Li Rose 5 Zhang Yaqiao 6 Li Yun 1 * Lv Yuan 1 * 1Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China 2Department of Trauma and Orthopaedics, Peking University People's Hospital, Beijing, China 3Department of General Surgery, Peking University First Hospital, Beijing, China 4Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China 5Department of Clinical Medicine, Civil Aviation General Hospital, Beijing, China 6Department of Clinical Medicine, Peking University International Hospital, Beijing, China Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland *Correspondence: Yun Li liyun03602@pkufh.com Yuan Lv lvyuan0901@sina.com †These authors share first authorship 19 6 2023 2023 19 6 2023 14 122427117 5 2023 02 6 2023 Copyright © 2023 Ko, Tseng, Chou, Li, Li, Zhang, Li and Lv. 2023 Ko, Tseng, Chou, Li, Li, Zhang, Li and Lv https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A corrigendum on Molecular epidemiology and comparative genomics of carbapenemase-producing Escherichia coli isolates from 19 tertiary hospitals in China from 2019 to 2020 by Ko, W., Tseng, S., Chou, C., Li, T., Li, R., Zhang, Y., Li, Y., and Lv, Y. (2023). Front. Microbiol. 14:1056399. doi: 10.3389/fmicb.2023.1056399 Escherichia coli carbapenemase molecular epidemiology genetic characteristics blaNDM gene section-at-acceptanceAntimicrobials, Resistance and Chemotherapy ==== Body pmcIn the original article, there was a typo error in the Author's List section. The author's name was incorrectly written as “Wehsin Ko.” The correct spelling is “Weihsin Ko.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.